Chlorpyrifos Exposure Lawsuit: Allegations of Pesticide-Induced Parkinson’s Disease

A California farmer has filed a lawsuit claiming that prolonged exposure to chlorpyrifos, a widely used pesticide, has led to his diagnosis of Parkinson’s disease. This lawsuit, filed by Robert Ranney and his wife, Jennifer, in the Philadelphia Court of Common Pleas, highlights the potential health risks associated with pesticide exposure, particularly for agricultural workers. The lawsuit has since been moved to the U.S. District Court for the Eastern District of Pennsylvania.

Understanding Chlorpyrifos and Its Uses in Agriculture

Chlorpyrifos is an organophosphate insecticide that has been utilized in agriculture since its introduction in the United States in 1965. It is primarily employed to control a variety of pests in crops, including fruits, vegetables, and grains. The chemical works by disrupting the normal functioning of the nervous system in insects, leading to their death.

Chlorpyrifos was initially marketed as a safer alternative to other pesticides and became widely used in agriculture, particularly on corn, soybeans, and other crops. The pesticide was also commonly used in residential settings until 2000, when most household uses were phased out in the United States. In 2020, Corteva Agriscience, one of the primary manufacturers of chlorpyrifos, announced that it would stop producing the pesticide.

Plaintiff’s Alleged Exposure to Chlorpyrifos

According to allegations raised in his chlorpyrifos lawsuit, Robert Ranney was exposed to chlorpyrifos over a period of several decades, including approximately 10 years of occupational exposure while working on farms. During that time, he alleges that he mixed and applied pesticides containing chlorpyrifos, resulting in repeated direct exposure to the chemical.

Ranney also alleges that he experienced additional environmental exposure while living near agricultural areas where chlorpyrifos was applied. The lawsuit claims that these combined exposures contributed to his development of Parkinson’s disease.

The complaint states that Ranney has experienced loss of motor function, physical pain, mental anguish, and other effects associated with his condition. He also alleges that his Parkinson’s disease has affected his quality of life and ability to work.

Research Examines Chlorpyrifos Exposure and Parkinson’s Disease

Ranney’s claims come amid research examining whether exposure to chlorpyrifos may be associated with an increased risk of Parkinson’s disease.

A UCLA-led study found that people with long-term residential exposure to chlorpyrifos had more than 2.5 times the risk of developing Parkinson’s disease compared with those who were not exposed. Researchers also examined the effects of chlorpyrifos in laboratory models and found that exposure produced inflammation and abnormalities involving dopamine-producing neurons, the brain cells that are progressively lost in Parkinson’s disease.

The findings provide additional evidence of a potential association between chlorpyrifos exposure and Parkinson’s disease. However, epidemiological associations do not establish that exposure caused Parkinson’s disease in any particular individual. Establishing whether chlorpyrifos contributed to Ranney’s diagnosis will be a central issue in his lawsuit.

What Does the Lawsuit Allege Against Chlorpyrifos Manufacturers?

Ranney’s lawsuit names companies associated with the manufacture and sale of chlorpyrifos products, including Corteva Agriscience and Dow Chemical Company. Ranney alleges that the defendants knew or should have known about potential health risks associated with exposure to chlorpyrifos but failed to provide adequate warnings. The complaint includes claims based on product liability and other legal theories and seeks damages related to Ranney’s alleged injuries and losses.

Regulatory Scrutiny of Chlorpyrifos

Chlorpyrifos has been the subject of extensive regulatory action in the United States, particularly concerning its potential effects on human health. The U.S. Environmental Protection Agency has evaluated the pesticide repeatedly over the past several decades, resulting in restrictions on where and how it may be used. Federal regulation of chlorpyrifos has also been the subject of litigation, including disputes over whether the pesticide should remain approved for use on food crops.

Individual states have taken additional action. California, where Ranney alleges much of his exposure occurred, ended virtually all agricultural use of chlorpyrifos beginning in 2020. The regulatory history of chlorpyrifos is separate from the question at issue in Ranney’s product liability lawsuit: whether his alleged exposure to chlorpyrifos caused or contributed to his Parkinson’s disease and whether the defendants can be held legally responsible.

Chlorpyrifos Lawsuits Raise Questions About Pesticide Exposure and Parkinson’s Disease

Ranney’s lawsuit comes amid broader litigation alleging that exposure to certain pesticides is associated with Parkinson’s disease. Similar claims have been brought against manufacturers of other agricultural chemicals, including the weedkiller paraquat, as researchers continue to investigate environmental factors that may contribute to the development of the disease.

Pesticide exposure cases can present complex questions of causation. Plaintiffs may need to establish the nature, duration, and extent of their exposure, as well as present scientific evidence supporting a connection between the chemical at issue and their diagnosed condition. 

For agricultural workers who handled pesticides like chlorpyrifos over extended periods, reconstructing historical exposure can be particularly important because the alleged exposures may have occurred years or decades before a diagnosis.

What Happens Next in the Chlorpyrifos Lawsuit?

Now that Ranney’s lawsuit has been moved to federal court, the litigation will proceed in the U.S. District Court for the Eastern District of Pennsylvania unless it is transferred, remanded, settled, dismissed, or otherwise resolved.

Among the issues likely to be disputed are the extent of Ranney’s chlorpyrifos exposure, whether scientific evidence can establish a causal connection between that exposure and his Parkinson’s disease, and whether the defendants adequately warned about potential health risks associated with their products.

The lawsuit remains at an early stage, and Ranney’s allegations have not been established in court. Its outcome will depend on the evidence presented, the applicable law, and how the court addresses the scientific and legal questions surrounding his claims.